Skip to content

CPB

S&P 500
Neutral · 50/100

Campbell's Company (The)

Consumer Staples
Packaged Foods & Meats

$20.40

3.5%

Updated Today 7:15 PM ET

Price — Past Year

▼ Down 33.6% over the last 12 months

Price 50-day average 200-day averageSource: Yahoo Finance · refreshed daily
Key Metrics

Market Cap

$6.31B

P/E

10.56x

Forward P/E (est.)

7.86x

ROE

15.3%

Revenue Growth

-2.9%

EPS Growth

34.2%

Profit Margin

6.1%

FCF Yield

19.0%

Debt / Equity

1.76x

ROIC

7.0%

Interest Coverage

3.26x

Current Ratio

0.87x

Dividend Yield

7.0%

Implied Growth (rev. DCF)

-2.0%

Rating Score

50/100

Technical Analysis (Educational)
Research

Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CPB's chart says today, with each tool explained.

Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CPB trades near $20.40, below its 50-day average ($20.92) and 200-day average ($26.53). Price below both averages is a downtrend — momentum is against buyers for now.

Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 50 it is in neutral territory — neither stretched nor washed out.

MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.

Volatility — ATR. Average True Range is the typical daily move. CPB's is $0.79 (~3.9% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.

Support & resistance. Over the last month CPB found buyers near $19.56 (support) and sellers near $23.24 (resistance); its 52-week range is $19.56–$34.17. A decisive break beyond either edge often marks the next move.

Volume. The latest session traded 5.0× the 20-day average — heavier than usual, which adds conviction to the move. Rising volume on up-days suggests real buying; on down-days, real selling.

Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.

Business Overview
Research

Campbell's Company (The) (CPB) is a mid-cap company in the Packaged Foods & Meats industry, part of the Consumer Staples sector of the S&P 500, with a market value around $6.31B.

In its latest reported year it generated about $10.25B in revenue and $602.00M in net profit.

Our model rates CPB Neutral (50/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Revenue Growth
Research

4Y CAGR

4.9%

Revenue moved from $8.48B in 2021 to $10.25B in 2025, a 4.9% compound annual growth rate. The most recent year declined 2.9% year over year. Shrinking revenue is worth a closer look — is it cyclical or structural?

Profitability
Research

Gross Margin

29.2%

Operating Margin

11.0%

Net Margin

5.9%

ROE

15.3%

Campbell's Company (The) keeps about 6.1% of each sales dollar as net profit, with a 29.2% gross margin and 11.0% operating margin. Return on equity is 15.3% and return on invested capital about 7.0%. Margins are moderate — typical of a competitive but profitable business.

Debt Analysis
Research

Total Debt

$8.03B

Net Debt

$7.63B

Net Debt / EBITDA

6.78x

Debt / Equity

1.76x

Leverage: debt-to-equity is 1.8x, and operating profit covers interest about 3.3x, with a current ratio of 0.9x. That is elevated leverage, which raises risk if earnings or rates move against it. It carries roughly $8.03B of total debt against $402.00M of cash.

Cash Flow Analysis
Research

Operating CF

$1.13B

Free Cash Flow

$705.00M

FCF Margin

6.9%

In the latest year Campbell's Company (The) produced about $1.13B of operating cash flow and $705.00M of free cash flow after capital spending. That is a free-cash-flow yield of about 19.0% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.

Valuation Analysis
Research

P/E

10.56x

P/S

0.64x

P/B

2.4x

EV / EBITDA

9.06x

CPB trades at 10.6x trailing earnings (about 7.9x on estimated forward earnings), 0.6x sales, and 2.4x book value. Reverse-engineering today's price implies the market expects roughly -2.0% long-term free-cash-flow growth. That is an undemanding multiple — potentially cheap if the business is stable.

Metrics vs. Typical Range

Where this stock sits versus what most companies trade at.

TTM P/E
10.6xCheap
Forward P/E
7.9xCheap
P/S ratio
0.6xCheap
Revenue growth
-2.9%Weak
EPS growth
34.2%Strong
Gross margin
29.2%Weak
Net margin
6.1%Weak
ROE
15.3%Average

Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.

Sector Peer Comparison

How CPB stacks up against its Consumer Staples peers — valuation, profitability, and growth versus the sector median.

In the Consumer Staples sector (36 S&P 500 companies), CPB ranks #15 of 36 by our overall rating. It trades at a discount versus the sector on earnings (10.6x P/E vs. 22.5x median) with a lower return on equity (15.3% vs. 20.2%) and slower revenue growth (-2.9% vs. 3.0%).

P/E vs sector

10.6x

median 22.5x

ROE vs sector

15.3%

median 20.2%

Growth vs sector

-2.9%

median 3.0%

Sector rank

#15

of 36 by rating

CompanyP/ERev Gr.Rating
CPBThis stock10.6x-2.9%Neutral· 50
CAG5.5x-4.7%Weak· 35
SJM3.7%Weak· 20
MKC7.6x5.7%Favorable· 71
HRL28.6x2.5%Weak· 39
GIS8.1x-6.5%Neutral· 42
TSN42.5x4.2%Weak· 26
KHC-1.8%Weak· 30
Consumer Staples median22.5x3.0%47/100

Valuation vs. quality map

sector medianCAGMKCHRLGISTSNCPBP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Consumer Staples companies by sub-industry and size. Sector median is across all 36 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$16.74$26.31

vs. $20.40 today · expected CAGR -4%5%

Metric20262027202820292030
Revenue$10.56B$10.88B$11.20B$11.54B$11.89B
Net income$633.64M$652.64M$672.22M$692.39M$713.16M
EPS$2.12$2.19$2.25$2.32$2.39
Share price (low)$14.87$15.32$15.78$16.25$16.74
Share price (high)$23.37$24.07$24.80$25.54$26.31
CAGR (low–high)-27% / 15%-13% / 9%-8% / 7%-6% / 6%-4% / 5%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for CPB:

  • Strong return on equity (15.3%) shows capital is put to work well.
  • Healthy free-cash-flow yield (~19.0%) funds buybacks and dividends.
  • Pays a 7.0% dividend on top of any price gains.
Bear Case

The case against CPB:

  • Revenue growth is slow/negative (-2.9%), limiting the upside engine.
  • Elevated leverage (debt/equity 1.8x) adds financial risk.
Key Risks
Research

Balance-sheet risk — debt/equity of 1.8x magnifies the impact of higher rates or weaker earnings.

Growth risk — sluggish revenue (-2.9%) leaves little margin for execution missteps.

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the picture is mixed: Campbell's Company (The) is a mid-cap consumer staples business with shrinking revenue, with modest profitability, and a heavier debt load to watch. It trades at 10.6x earnings, which our model scores Neutral (50/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.